Back
DJS Antibodies

DJS Antibodies

djsantibodies.com

DJS Antibodies is a pre-clinical biotech company using their proprietary antibody discovery platform to design better treatments for patients with severe inflammatory disorders. DJS was acquired by AbbVie in 2022.

What
Life Sciences
When
Jul 2014
CEO
David Llewellyn
Status
Private
Investment
Exited
PreviousNext